Abstract

The present disclosure relates to a process for the preparation of (4-Fluorophenyl)[(8R)-8-methyl-3-(3-methyl-1,2,4-thiadiazol-5-yl)-5,6-dihydro[1,2,4] triazolo [4,3-a] pyrazin-7(8H)-yl] methanone of formula-1 and its intermediates thereof. The structure of formula-1 is shown below:

Formula-1.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Share

COinS